報道指中證監擬提升科創板上市門檻 螞蟻上市難度增加
《彭博通訊社》引述消息人士指,中證監擬最快下月提高於上海科創板首次上市公司的要求,將要求上市公司提供科技能力的證明,對其「硬技術」及創新能力有更高要求,並將對其財務報表進行更嚴格的審查,變相提升公司上市門檻。
報道指,雖然新規未有指明針對行業,惟相信對於金融科技公司如螞蟻集團的上市難度將增加。中證監及上交所未有對報道作出回應。報道並指,有關消息傳開後,部分公司擬放棄於上海科創板的上市計劃,轉向深圳創業板或上交所主板上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.